KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Equity (2018 - 2025)

Historic Return on Equity for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to 0.33%.

  • Moderna's Return on Equity fell 1400.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.29% for FY2024, which is 0.0% changed from last year.
  • Per Moderna's latest filing, its Return on Equity stood at 0.33% for Q3 2025, which was down 1400.0% from 0.3% recorded in Q2 2025.
  • In the past 5 years, Moderna's Return on Equity ranged from a high of 1.01% in Q4 2021 and a low of 0.48% during Q2 2024
  • Its 5-year average for Return on Equity is 0.15%, with a median of 0.07% in 2023.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 12900bps in 2021, then tumbled by -8800bps in 2023.
  • Moderna's Return on Equity (Quarter) stood at 1.01% in 2021, then plummeted by -55bps to 0.45% in 2022, then tumbled by -177bps to 0.35% in 2023, then increased by 10bps to 0.31% in 2024, then fell by -7bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.3% for Q2 2025, and 0.32% during Q1 2025.